Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Fenghua Pharmaceutical Technology is a specialized pharmaceutical enterprise focused on the research, development, and manufacturing of active pharmaceutical ingredients (APIs) and advanced chemical intermediates. Based in the Hangzhou Bay Shangyu Economic and Technological Development Zone, the company has established a strong portfolio in cardiovascular, anti-infective, and metabolic therapeutic areas. Its core products include high-purity statins such as Rosuvastatin and Pitavastatin, as well as antifungal agents like Luliconazole. Zhejiang Fenghua operates as a key supplier and CDMO partner for global pharmaceutical firms, leveraging its GMP-compliant facilities and expertise in complex organic synthesis. The company is dedicated to technological innovation and quality management to meet international regulatory standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhejiang Fenghua Pharmaceutical Technology.